Molecular Targets 2021: Examining Synthetic Lethality Beyond PARP Inhibitors
Cancer is a very complex disease. Cancer cells often have the ability to rewire some of their functions to survive in harsh...
Cancer is a very complex disease. Cancer cells often have the ability to rewire some of their functions to survive in harsh...
As you snack on turkey sandwiches and leftover pumpkin pie, check out the articles highlighted by the editors of...
November is National Family Caregivers Month, which honors the role of caregivers in communities. The book “Already Toast: Caregiving...
The American Association for Cancer Research (AACR) is proud to announce a new collaboration with a grants program aimed at...
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research, has been honored with the...
“If our patients are diverse, why are clinical trials so white?” Vanessa Sheppard, PhD, invoked this quote from author and...
While cancer and COVID-19 are, biologically, very different diseases, they have shaken the world in surprisingly similar ways. Nearly...
Among the studies published during the month of October in the nine AACR journals, the editors have chosen to highlight results from two clinical trials of DNA...
As the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved got underway...
Each month, the editors of the nine AACR journals select one article from each issue to highlight. The featured articles for September described the preclinical evaluation...